Catherine is a seasoned finance executive with 20 years of international experience at senior levels in major investment banks and as a C-level executive in listed and private biotech companies across Europe.
Catherine Moukheibir has been appointed an Independent Director of Ablynx
Catherine is a seasoned finance executive with 20 years of international experience at senior levels in major investment banks and as a C-level executive in listed and private biotech companies across Europe.
Tags
Related posts
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
- Study links dementia antipsychotics to higher risks of serious health outcomes
- New clinical trial aims to investigate skin patches to spot lung transplant rejection
